A detailed history of Centiva Capital, LP transactions in Danaher Corp stock. As of the latest transaction made, Centiva Capital, LP holds 16,365 shares of DHR stock, worth $3.75 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
16,365
Previous 4,240 285.97%
Holding current value
$3.75 Million
Previous $1.06 Million 329.56%
% of portfolio
0.09%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $2.9 Million - $3.4 Million
12,125 Added 285.97%
16,365 $4.55 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $998,562 - $1.14 Million
4,240 New
4,240 $1.06 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $1.54 Million - $1.76 Million
6,622 New
6,622 $1.64 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $1.84 Million - $2.13 Million
7,685 New
7,685 $1.94 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $29,894 - $182,395
121 New
121 $31,000
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $2.37 Million - $3 Million
10,000 New
10,000 $2.54 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $821,328 - $925,176
-2,812 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $306,236 - $373,983
1,125 Added 66.69%
2,812 $856,000
Q2 2021

Aug 16, 2021

BUY
$225.08 - $271.69 $379,709 - $458,341
1,687 New
1,687 $453,000
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $582,558 - $674,503
-2,743 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $582,887 - $673,296
2,743 New
2,743 $609,000
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $2.14 Million - $2.9 Million
-21,900 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$94.85 - $109.54 $2.08 Million - $2.4 Million
21,900 New
21,900 $2.26 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.